Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Lancet

• Publication date

  1999-07-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(99)01354-9PMID 10437875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.

  1999cited by this paper
• Experimental evidence to support ELITE.

  1998cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.

  1996cited by this paper
• QT dispersion and sudden unexpected death in chronic heart failure.

  1994cited by this paper

• Increased QT Dispersion and High Risk of Ventricular Arrhythmias is Associated with Hyperuricemia in Individuals with Normal Renal Function

  2021cites this paper
• QT Dispersion and Drug-Induced Torsade de Pointes

  2021cites this paper
• Protein kinase C epsilon mediates the inhibition of angiotensin II on the slowly activating delayed-rectifier potassium current through channel phosphorylation.

  2018cites this paper
• Different protein kinase C isoenzymes mediate inhibition of cardiac rapidly activating delayed rectifier K+ current by different G‐protein coupled receptors

  2017cites this paper
• Usefulness of QT dispersion in clinical practice

  2016cites this paper
• Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis

  2014cites this paper
• ЗНАЧЕНИЕ ПРОДОЛЖИТЕЛЬНОСТИ ИНТЕРВАЛА QT ЭКГ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ

  2012cites this paper
• Angiotensin II Receptor Antagonists in Chronic Heart Failure

  2012cites this paper
• The effect of contrast dye injection and balloon inflation on QTC and QTC dispersion in 12 leads surface EKG during PTCA

  2011cites this paper
• Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients Hipertansif hastalarda valsartan ve nebivololun, kan basinci, QT dağilimi ve sol ventrikül hipertrofisi üzerine etkileri

  2010cites this paper
• Utilità della dispersione del QT nella pratica clinica Usefulness of QT dispersion in clinical practice

  2009cites this paper
• Cardiovascular effects of losartan and its relevant clinical application.

  2009cites this paper
• THE EFFECT OF THE TYPE OF HEMODIALYSIS BUFFER ON THE QTC INTERVAL IN PATIENTS ON CHRONIC HEMODIALYSIS

  2009cites this paper
• Ventricular repolarization during cardiovascular autonomic function testing

  2008cites this paper
• Inhibition of the rapid component of the delayed rectifier potassium current in ventricular myocytes by angiotensin II via the AT1 receptor

  2008cites this paper
• HipertansifHastalardaKinaprilveNebivolol'ünQT Dispersiyonu ÜzerineEtkileri

  2007cites this paper
• Hipertansif Hastalarda Kinapril ve Nebivolol’ün QT Dispersiyonu Üzerine Etkileri

  2007cites this paper
• Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.

  2006cites this paper
• Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.

  2006cites this paper
• Angiotensin receptor blockers for chronic heart failure

  2006cites this paper
• Clinical implication of T-wave morphology analysis as a new repolarization descriptor.

  2005cites this paper
• QT and P wave dispersion QT ve

  2005cites this paper
• Drugs Blocking the Renin-Angiotensin-Aldosterone System

  2004cites this paper
• Angiotensin Receptor Type 1 Forms a Complex with the Transient Outward Potassium Channel Kv4.3 and Regulates Its Gating Properties and Intracellular Localization*

  2004cites this paper
• Preconditioning Reduces QTc Value in Patients with First Non‐ST‐Segment Elevation Myocardial Infarction (NSTEMI)

  2003cites this paper
• QT Dispersion and Mental Stress Testing

  2003cites this paper
• QT Dispersion Has No Prognostic Value in Patients with Symptomatic Heart Failure: An ELITE II Substudy

  2003cites this paper
• Evaluation of Ventricular Repolarization

  2003cites this paper
• Effects of spironolactone and metoprolol on QT dispersion in heart failure.

  2003cites this paper
• Sympatholytic therapy in primary hypertension: a user friendly role for the future

  2002cites this paper
• Reduction of QT Dispersion by Losartan in Patients with Mild to Moderate Hypertension

  2002cites this paper
• Efficacy of Angiotensin II Type 1 Receptor Blockade on Reperfusion-Induced Arrhythmias and Mortality Early After Myocardial Infarction Is Increased in Transgenic Rats With Cardiac Angiotensin II Type 1 Overexpression

  2002cites this paper
• Angiotensin II receptor antagonists in chronic heart failure: where do they fit?

  2002cites this paper
• Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

  2001cites this paper
• Angiotensin II provokes cesium-induced ventricular tachyarrhythmias.

  2001cites this paper
• The clinical utility of QT interval assessment in diabetes.

  2000cites this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cites this paper
• Measurement, interpretation and clinical potential of QT dispersion.

  2000cites this paper
• Beyond ACE Inhibitors: Angiotensin II Antagonism in Heart Failure, An Emerging Role for Losartan

  2000cites this paper
• Renin angiotensin system and ASCVD

  2000cites this paper
• Heart Failure

  2000influential citation
• Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.

  2000cites this paper
• Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.

  1999cites this paper